A Study of Clinical Profile and Outcome of De Novo Acute Heart Failure Patients in Tertiary Care Hospital in South India

Full Article PDF Review History

Published: 2023-07-20

Page: 259-267

Palani Kannan *

Department of Cardiology, Apollo Hospital, Chennai-06, India.

Rajeshwari Nayak

Department of Cardiology, Apollo Hospital, Chennai-06, India.

*Author to whom correspondence should be addressed.


Introduction: Acute heart failure is widely described as the sudden emergence of new or worsening Heart failure signs and symptoms. With a better understanding of the many risk factors and etiology of heart failure, attention to the finer points of heart failure care with novel diagnostic techniques and various outcomes and prognosis of AHF patients, this study will assist us in providing a clearer understanding of the analysis of numerous risk factors, etiology, and outcomes of patients with acute heart failure. To study the clinical profile, etiology, and outcome of DE NOVO acute heart failure in a tertiary care centre and to identify their co-morbidities and factors associated with increased mortality.

Methodology: A total of 110 patients were taken into the study after informed consent and passing inclusion and exclusion criteria. Based on the Boston criteria for diagnosing heart failure, heart failure patients newly diagnosed were enrolled as “ De Novo Acute Heart Failure patients” and they were studied. Hospital records & databases confirmed, based on the proforma and symptomatology questionnaire, patient characteristics taken, BMI, lifestyle and personal habits were noted. On admission, blood investigations like NT-Pro-BNP, CBC, LFT, RFT, +/- anaemia profile, blood, and urine C/S, kerley B lines, and ECHO assessment for Left ventricular function were done and analyzed. All the data collected were tabulated in excel sheet, analyzed.

Results: Diabetes (70%) and Hypertension (67.3%) are the common co-morbidities associated with heart failure. Ischemic heart disease (48.2%) is the most common etiology. Atrial fibrillation is the most common arrhythmia (12.7%), and iron deficiency anaemia (81%) is one of the preventable precipitating factors of acute heart failure. Our study shows a mortality rate of 6.4%. Cerebrovascular events were noted in a greater number of patients.

Conclusion: Our study is a cutting-edge investigation of de novo acute cardiac failure stating the relationship between polyvascular disease and the higher incidence of risk factors. Our study is one of the novel studies done for de novo acute heart failure in India. Ischemic heart disease is the most common etiology followed by valvular heart disease for acute De Novo heart failure.

Keywords: De Novo acute heart failure, cardiovascular disease, ischemic heart disease, cerebrovascular events, left ventricular dysfunction

How to Cite

Kannan , P., & Nayak , R. (2023). A Study of Clinical Profile and Outcome of De Novo Acute Heart Failure Patients in Tertiary Care Hospital in South India. Asian Journal of Cardiology Research, 6(1), 259–267. Retrieved from https://journalajcr.com/index.php/AJCR/article/view/167


Download data is not yet available.


Gheorghiade M, Mebazaa A. Introduction to acute heart failure syndromes. American Journal of Cardiology. 2005 Sep 19; 96(6):1-4.

Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007 Sep 1;93(9):1137-46.

van Riet EE, Hoes AW, Wagenaar KP, Limburg A, Landman MA, Rutten FH. Epidemiology of heart failure: The prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. European Journal of Heart Failure. 2016 Mar;18(3): 242-52.

Но КК, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: Framingham Study. JACC. 1993;22(Suppl A):6A- 13.

Chaturvedi V, Parakh N, Seth S, Bhargava B, Ramakrishnan S, Roy A, Saxena A, Gupta N, Misra P, Rai SK, Anand K. Heart failure in India: the INDUS (INDia ukieri study) study. Journal of the Practice of Cardiovascular Sciences. 2016;2(1):28- 35.

James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, Abdollahpour I. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018 Nov 10;392(10159):1789-858.

Lawson CA, Zaccardi F, Squire I, Okhai H, Davies M, Huang W, Mamas M, Lam CS, Khunti K, Kadam UT. Risk factors for heart failure: 20-year population-based trends by sex, socioeconomic status, and ethnicity. Circulation: Heart Failure. 2020 Feb;13(2): e006472.

Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003 Nov 19; 290(19):2581-7.

Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ. Quality of care for elderly patients hospitalized with heart failure. Archives of Internal Medicine. 1997 Oct 27;157(19): 2242-7.

de Simone G, Devereux RB, Chinali M, Lee ET, Galloway JM, Barac A, Panza JA, Howard BV. Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. Journal of Hypertension. 2010 Feb;28(2): 353.

Pranata R, Tondas AE, Yonas E, Vania R, Yamin M, Chandra A, Siswanto BB. Differences in clinical characteristics and outcome of de novo heart failure compared to acutely decompensated chronic heart failure–systematic review and meta-analysis. Acta Cardiologica. 2021 Jul 4;76(4):410-20.

Choi KH, Choi JO, Jeon ES, Lee GY, Choi DJ, Lee HY, Kim JJ, Chae SC, Baek SH, Kang SM, Yoo BS. Guideline‐directed medical therapy for patients with heart failure with midrange ejection fraction: a patient‐pooled analysis from the Kor HF and Kor AHF registries. Journal of the American Heart Association. 2018 Nov 6;7(21):e009806.

Degoricija V, Trbušić M, Potočnjak I, Radulović B, Terešak SD, Pregartner G, Berghold A, Tiran B, Frank S. Acute heart failure developed as worsening of chronic heart failure is associated with increased mortality compared to de novo cases. Scientific Reports. 2018 Jun 25;8(1):1- 6.

AlHabib KF, Kashour T, Elasfar AA, Alfaleh H, Hersi A, Alshamiri M, Alshaer F, Mimish L, Almasood A, AlHabeeb W, AlGhamdi S. Long-term mortality rates in acute de novo versus acute-on-chronic heart failure: From the heart function assessment registry trial in Saudi Arabia. Angiology. 2015 Oct;66(9):837- 44.

Younis A, Mulla W, Goldkorn R, Klempfner R, Peled Y, Arad M, Freimark D, Goldenberg I. Differences in mortality of new-onset (de-novo) acute heart failure versus acute decompensated chronic heart failure. The American Journal of Cardiology. 2019 Aug 15; 124(4):554-9.